동맥 캐뉼라 시장 - 규모, 점유율, 동향 분석 보고서 : 용도별, 사이즈별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Arterial Cannula Market Growth & Trends:

The global arterial cannula market size is projected to reach USD 33.4 million by 2030, registering a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research. An increase in the prevalence of chronic diseases is leading to a rise in surgical procedures, which is driving the growth of the industry. According to an article published by the National Library of Medicine in September 2020, an overwhelming 310 million major surgeries are performed each year; around 20 million in Europe and about 40 to 50 million in the USA. Furthermore, advancements in minimally invasive surgeries are driving product demand. Minimally invasive techniques and cutting-edge technology give patients fast recovery time, less pain, and the best aesthetic results.

These advantages have resulted in the increasing adoption of minimally invasive techniques, which is leading to an increasing number of patients opting to undergo these surgical interventions. The COVID-19 pandemic resulted in a temporary fall in product sales. This is due to the postponement of elective surgeries to avoid the spread of the virus and focus dedicatedly on combatting the COVID-19 virus. However, the market began to quickly recover in the second half of the pandemic with increasing efforts of healthcare professionals and different strategies led down at the micro as well as macro-economic levels. The industry is further expected to experience significant demand over the forecast period with governments of various countries majorly focusing on healthcare to avoid similar situations in the future. Moreover, increasing investments in the healthcare sector are also expected to boost the overall industry growth over the forecast period.

Arterial Cannula Market Report Highlights:

• The ECMO segment held the highest revenue share in 2024 owing to the increasing adoption of the arterial cannula for oxygenation
• The cardiopulmonary bypass surgery segment is projected to experience the fastest CAGR over the forecast period due to the increasing prevalence of cardiac diseases
• The 20-22 Fr size segment led the market, in terms of revenue share in 2024 as these are the most commonly used arterial cannulas
• The hospitals segment held the largest share in 2024 as the majority of surgical procedures are carried out in these settings
• The ASCs segment will register the fastest growth rate over the forecast period due to favorable reimbursement initiatives by various governments

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Size
  • 1.2.3. End use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Size outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Arterial Cannula Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Increasing geriatric population
    • 3.2.1.3. Rise in number of surgical procedures
    • 3.2.1.4. Advancements in minimally invasive surgeries
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. Product recalls
• 3.3. Arterial Cannula Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Arterial Cannula Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Arterial Cannula Market: Application Movement Analysis
• 4.3. Arterial Cannula Market by Application Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Cardiopulmonary Bypass Surgery
  • 4.5.1. Cardiopulmonary Bypass Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Extracorporeal Membrane Oxygenation (ECMO)
  • 4.6.1. Extracorporeal Membrane Oxygenation (ECMO) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Arterial Cannula Market: Size Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Arterial Cannula Market: Size Movement Analysis
• 5.3. Arterial Cannula Market by Size Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. 14-16 Fr
  • 5.5.1. 14-16 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. 17-19 Fr
  • 5.6.1. 17-19 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. 20-22 Fr
  • 5.7.1. 20-22 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. 23-25 Fr
  • 5.8.1. 23-25 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. 26-28 Fr
  • 5.9.1. 26-28 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. 29- 31 Fr
  • 5.10.1. 29- 31 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.11. 32-34 Fr
  • 5.11.1. 32-34 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.12. 35-36 Fr
  • 5.12.1. 35-36 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Arterial Cannula Market: End use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Arterial Cannula Market: End use Movement Analysis
• 6.3. Arterial Cannula Market by End use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Arterial Cannula Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Arterial Cannula Market Movement Analysis
• 7.3. Arterial Cannula Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement scenario
    • 7.5.2.5 U.S. Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Reimbursement scenario
    • 7.5.3.5 Canada Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement scenario
    • 7.5.4.5 Mexico Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1 Key Country Dynamics
    • 7.5.7.2 Competitive Scenario
    • 7.5.7.3 Regulatory Framework
    • 7.5.7.4 Reimbursement scenario
    • 7.5.7.5 UK Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1 Key Country Dynamics
    • 7.5.8.2 Competitive Scenario
    • 7.5.8.3 Regulatory Framework
    • 7.5.8.4 Reimbursement scenario
    • 7.5.8.5 Germany Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1 Key Country Dynamics
    • 7.5.9.2 Competitive Scenario
    • 7.5.9.3 Regulatory Framework
    • 7.5.9.4 Reimbursement scenario
    • 7.5.9.5 France Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1 Key Country Dynamics
    • 7.5.10.2 Competitive Scenario
    • 7.5.10.3 Regulatory Framework
    • 7.5.10.4 Reimbursement scenario
    • 7.5.10.5 Italy Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1 Key Country Dynamics
    • 7.5.11.2 Competitive Scenario
    • 7.5.11.3 Regulatory Framework
    • 7.5.11.4 Reimbursement scenario
    • 7.5.11.5 Spain Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1 Key Country Dynamics
    • 7.5.12.2 Competitive Scenario
    • 7.5.12.3 Regulatory Framework
    • 7.5.12.4 Reimbursement scenario
    • 7.5.12.5 Denmark Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1 Key Country Dynamics
    • 7.5.13.2 Competitive Scenario
    • 7.5.13.3 Regulatory Framework
    • 7.5.13.4 Reimbursement scenario
    • 7.5.13.5 Sweden Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1 Key Country Dynamics
    • 7.5.14.2 Competitive Scenario
    • 7.5.14.3 Regulatory Framework
    • 7.5.14.4 Reimbursement scenario
    • 7.5.14.5 Norway Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.15. Asia Pacific
  • 7.5.16. Asia Pacific Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.17. Japan
    • 7.5.17.1 Key Country Dynamics
    • 7.5.17.2 Competitive Scenario
    • 7.5.17.3 Regulatory Framework
    • 7.5.17.4 Reimbursement scenario
    • 7.5.17.5 Japan Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.18. China
    • 7.5.18.1 Key Country Dynamics
    • 7.5.18.2 Competitive Scenario
    • 7.5.18.3 Regulatory Framework
    • 7.5.18.4 Reimbursement scenario
    • 7.5.18.5 China Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.19. India
    • 7.5.19.1 Key Country Dynamics
    • 7.5.19.2 Competitive Scenario
    • 7.5.19.3 Regulatory Framework
    • 7.5.19.4 Reimbursement scenario
    • 7.5.19.5 India Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.20. South Korea
    • 7.5.20.1 Key Country Dynamics
    • 7.5.20.2 Competitive Scenario
    • 7.5.20.3 Regulatory Framework
    • 7.5.20.4 Reimbursement scenario
    • 7.5.20.5 South Korea Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.21. Australia
    • 7.5.21.1 Key Country Dynamics
    • 7.5.21.2 Competitive Scenario
    • 7.5.21.3 Regulatory Framework
    • 7.5.21.4 Reimbursement scenario
    • 7.5.21.5 Australia Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.22. Thailand
    • 7.5.22.1 Key Country Dynamics
    • 7.5.22.2 Competitive Scenario
    • 7.5.22.3 Regulatory Framework
    • 7.5.22.4 Reimbursement scenario
    • 7.5.22.5 Thailand Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.23. Latin America
  • 7.5.24. Latin America Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.25. Brazil
    • 7.5.25.1 Key Country Dynamics
    • 7.5.25.2 Competitive Scenario
    • 7.5.25.3 Regulatory Framework
    • 7.5.25.4 Reimbursement scenario
    • 7.5.25.5 Brazil Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.26. Argentina
    • 7.5.26.1 Key Country Dynamics
    • 7.5.26.2 Competitive Scenario
    • 7.5.26.3 Regulatory Framework
    • 7.5.26.4 Reimbursement scenario
    • 7.5.26.5 Argentina Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.27. Middle East & Africa
  • 7.5.28. Middle East & Africa Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.29. South Africa
    • 7.5.29.1 Key Country Dynamics
    • 7.5.29.2 Competitive Scenario
    • 7.5.29.3 Regulatory Framework
    • 7.5.29.4 Reimbursement scenario
    • 7.5.29.5 South Africa Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.30. Saudi Arabia
    • 7.5.30.1 Key Country Dynamics
    • 7.5.30.2 Competitive Scenario
    • 7.5.30.3 Regulatory Framework
    • 7.5.30.4 Reimbursement scenario
    • 7.5.30.5 Saudi Arabia Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.31. UAE
    • 7.5.31.1 Key Country Dynamics
    • 7.5.31.2 Competitive Scenario
    • 7.5.31.3 Regulatory Framework
    • 7.5.31.4 Reimbursement scenario
    • 7.5.31.5 UAE Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.32. Kuwait
    • 7.5.32.1 Key Country Dynamics
    • 7.5.32.2 Competitive Scenario
    • 7.5.32.3 Regulatory Framework
    • 7.5.32.4 Reimbursement scenario
    • 7.5.32.5 Kuwait Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Medtronic, plc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Application benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. LivaNova plc
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Application benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Edward Lifesciences
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Application benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Getinge AB
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Application benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Fresenius Medical Care
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Application benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. BD
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Application benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Nipro Corp.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Application benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Andocor
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Application benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Freelife Medical GmbH
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Application benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Surgical Holdings
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Application benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Kangxin Medical
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Application benchmarking
    • 8.2.11.4. Strategic initiatives